Full Text View
Tabular View
No Study Results Posted
Related Studies
6-mo. Min Eff Dose of Flibanserin: 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA
This study has been completed.
Study NCT00360243   Information provided by Boehringer Ingelheim Pharmaceuticals
First Received: August 3, 2006   Last Updated: April 24, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sexual Dysfunctions, Psychological
More general conditions related to this trial
Mental Disorders
Sexual and Gender Disorders
Interventions listed in this trial
flibanserin
placebo
Sponsors listed in this trial
Boehringer Ingelheim Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services